Patidar Buildcon Limited

BSE: PATIDAR

BSE

7.68 0.00 (0.00%)

Prev Close

7.68

Open Price

7.68

Volume

509

Today Low / High

7.68 / 7.68

52 WK Low / High

7.02 / 16.1

Range

7 - 8

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 7.68, reflecting a change of 0 (0%). The expected target range on the BSE is 7 - 8. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

05 Aug 7.65 0.00%

04 Aug 7.65 0.00%

30 Jul 7.47 0.00%

28 Jul 7.50 0.00%

25 Jul 7.50 0.00%

24 Jul 7.50 0.00%

22 Jul 7.50 0.00%

21 Jul 7.46 0.00%

Patidar Buildcon Limited Graph

If you are looking for the target price for Patidar Buildcon Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 7.68, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario	Price	Target	Range
Bullish Scenario	7.68	7.76	6.98 - 8.53
		7.83	6.27 - 9.40
		7.91	5.54 - 10.28
Bearish Scenario	7.68	7.60	6.84 - 8.36
		7.53	6.02 - 9.03
		7.45	5.21 - 9.68

ISIN

INE637N01014

Industry

Medical - Pharmaceuticals

Vol.Avg

366

Market Cap

42,079,361

Last Dividend

Official Website

Visit Website

IPO Date

2011-08-29

DCF Diff

3.09

DCF

Financial Ratios Every Investor Needs

Stock Rating Details for PATIDAR

Metric	Value	Recommendation
Overall Rating	C-	Strong Sell
DCF Score	3	Neutral
ROE Score	1	Strong Sell
ROA Score	1	Strong Sell
Debt-to-Equity (DE) Score	2	Sell
Price-to-Earnings (PE) Score	1	Strong Sell
Price-to-Book (PB) Score	1	Strong Sell

Annual Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	G&A Expenses	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	1.16 Cr	1.04 Cr	0.12 Cr	0.1055	0.00 Cr	-0.41 Cr	-0.37 Cr	-0.66	-0.16 Cr	-0.3219
2024-03-31	0.23 Cr	0.23 Cr	0.00 Cr	-0.0113	0.06 Cr	-0.34 Cr	-0.10 Cr	-0.17	0.16 Cr	-0.4142
2023-03-31	0.96 Cr	0.77 Cr	0.19 Cr	0.1968	0.02 Cr	-0.15 Cr	0.02 Cr	0.04	-0.17 Cr	0.0230
2022-03-31	1.45 Cr	1.28 Cr	0.17 Cr	0.1172	0.03 Cr	-0.20 Cr	0.16 Cr	0.29	-0.19 Cr	0.1087
2021-03-31	1.04 Cr	1.03 Cr	0.01 Cr	0.0051	0.09 Cr	-0.42 Cr	0.16 Cr	0.29	-0.41 Cr	0.1562

Annual Financials Balance Sheet

Date	C&C Equ.	Tot. Assets	Tot. Liab.	Stock. Equity	Tot. Debt	Net Debt	Inv.	PP&E (Net)	Curr. Def. Rev.	LT Invest.	Curr. Liab.
2025-03-31	0.10 Cr	8.96 Cr	2.46 Cr	6.4975 Cr	2.20 Cr	2.10 Cr	1.37 Cr	0.36 Cr	0.00 Cr	0.17 Cr	0.2538 Cr
2024-03-31	0.26 Cr	9.43 Cr	2.56 Cr	6.8704 Cr	5.06 Cr	4.80 Cr	1.26 Cr	0.37 Cr	0.00 Cr	0.18 Cr	2.5506 Cr
2023-03-31	0.01 Cr	10.62 Cr	3.65 Cr	6.9661 Cr	3.51 Cr	3.50 Cr	1.42 Cr	0.19 Cr	0.41 Cr	3.10 Cr	4.0957 Cr
2022-03-31	0.27 Cr	7.29 Cr	0.34 Cr	6.9441 Cr	0.00 Cr	-0.27 Cr	1.54 Cr	0.20 Cr	0.00 Cr	-1.29 Cr	0.3413 Cr
2021-03-31	0.32 Cr	6.87 Cr	0.08 Cr	6.7863 Cr	0.00 Cr	-0.32 Cr	1.58 Cr	0.22 Cr	0.00 Cr	-1.60 Cr	0.0787 Cr

Annual Financials Cash Flow Statement

Date	Operating Cash	Investing Cash	Financing Cash	Free Cash	Cash Change	Cash at End	CapEx	Income	Debt Repay	Inventory
2025-03-31	0.5415 Cr	-0.1850 Cr	-0.5188 Cr	0.5276 Cr	-0.1622 Cr	0.1008 Cr	-0.0139 Cr	-0.3700 Cr	-0.3345 Cr	-0.1045 Cr
2024-03-31	1.3187 Cr	-0.1750 Cr	-0.9326 Cr	1.2285 Cr	0.2111 Cr	0.2631 Cr	-0.0902 Cr	-0.0833 Cr	-0.9326 Cr	0.1639 Cr
2023-03-31	-0.4813 Cr	-3.3150 Cr	3.5792 Cr	-0.7924 Cr	-0.2170 Cr	0.0520 Cr	-0.3111 Cr	0.0258 Cr	3.5792 Cr	0.1182 Cr
2022-03-31	-0.4285 Cr	0.3781 Cr	0.0000 Cr	-0.4292 Cr	-0.0504 Cr	0.2690 Cr	-0.0007 Cr	0.1802 Cr	0.0000 Cr	0.0352 Cr
2021-03-31	0.8507 Cr	-0.7140 Cr	-0.0409 Cr	0.6606 Cr	0.0958 Cr	0.3194 Cr	-0.1901 Cr	0.1748 Cr	-0.6450 Cr	0.1769 Cr

Quarterly Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	0.31 Cr	0.31 Cr	0.01 Cr	0.0188	-0.03 Cr	-0.17 Cr	-0.30	0.20 Cr	-0.5450
2024-12-31	0.52 Cr	0.45 Cr	0.06 Cr	0.1234	-0.13 Cr	-0.10 Cr	-0.18	-0.12 Cr	-0.1961
2024-09-30	0.29 Cr	0.24 Cr	0.05 Cr	0.1739	-0.13 Cr	-0.08 Cr	-0.14	-0.13 Cr	-0.2680
2024-06-30	0.04 Cr	0.04 Cr	0.00 Cr	0.0654	-0.12 Cr	-0.02 Cr	-0.04	-0.12 Cr	-0.5787
2024-03-31	0.00 Cr	0.00 Cr	0.00 Cr	0.0322	-0.12 Cr	0.01 Cr	0.01	-0.12 Cr	1.7394

Quarterly Financials Balance Sheet

Date	Cash & Equiv.	Short-Term Inv.	Cash & Short-Term	Net Receivables	Inventory	Total Curr. Assets	PP&E (Net)	Total Assets	Total Liabilities
2025-03-31	0.10 Cr	0.36 Cr	0.46 Cr	0.14 Cr	1.37 Cr	1.96 Cr	0.36 Cr	8.96 Cr	2.46 Cr
2024-12-31	0.00 Cr	0.00 Cr	0.05 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-6.77 Cr
2024-09-30	0.03 Cr	0.49 Cr	0.51 Cr	0.00 Cr	1.25 Cr	2.27 Cr	0.50 Cr	9.33 Cr	2.56 Cr
2024-06-30	0.00 Cr	0.00 Cr	0.26 Cr	0.00 Cr	0.00 Cr	0.26 Cr	0.00 Cr	0.00 Cr	-6.87 Cr
2024-03-31	0.02 Cr	0.24 Cr	0.26 Cr	0.71 Cr	1.26 Cr	2.53 Cr	5.59 Cr	9.43 Cr	2.56 Cr

Quarterly Financials Cash Flow Statement

Date	Net Income	Operating Cash Flow	Investing Cash Flow	Financing Cash Flow	Net Cash Change	Cash at End	Cash at Beginning	CapEx	Free Cash Flow
2024-12-31	-0.10 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-09-30	-0.08 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-06-30	-0.02 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-03-31	0.01 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2023-12-31	-0.13 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr

Splits History

Date	Label	Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name	Symbol	Price	Market Cap	Volume
MedPlus Health Services Limited	MEDPLUS	₹804.05	₹96,279,696,851.00	₹756,659.00

Key Executives

Company Secretary & Compliance Officer

Ms. Vaidehi Dharmendrasinh Chudasama

Gender: female

Year Born:

Chairman & MD

Mr. Rajnikant Ramjibhai Patel

Gender: male

Year Born: 1971

Chief Financial Officer

Mr. Dharmendra Dalsukhbhai Shah

Gender: male

Year Born:

FAQs about Patidar Buildcon Limited

Who is the CEO of the company?

The CEO is Rajnikant Ramjibhai Patel.

What is the current market price of the stock?

The current price is ₹7.65.

What is the 52-week price range?

The range is ₹7.02-16.1.

What is the market capitalization of the company?

The market capitalization is ₹4.21 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -11.68.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Patidar Buildcon Limited (ISIN: INE637N01014) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹4.21 crores and an average daily volume of 366 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.